Former CFO Sandip Kapadia Files Intent to Sell $1.6M in Stock
HRMY sits 39% above its 52-week low of $25.52 on elevated volume (2.1× avg).
Summary
Former CFO Sandip Kapadia filed a Form 144 to sell $1.6 million worth of Harmony Biosciences stock, continuing a trend of share dispositions by the former executive.
Key Events · Ownership and Investor Activity · HRMY
-
Intent to Sell Shares
Former CFO Sandip Kapadia filed a Form 144 to sell 45,594 shares of common stock, valued at approximately $1.6 million.
-
Acquisition via Option Exercise
The shares intended for sale were acquired through the exercise of options under a registered plan.
-
Ongoing Executive Sales
This filing is part of a pattern, as Kapadia has sold an additional 87,012 shares totaling over $2.8 million in gross proceeds over the past three months.
Analysis · HRMY · Life Sciences
Former CFO Sandip Kapadia has filed a Form 144 indicating his intent to sell 45,594 shares of Harmony Biosciences stock, valued at approximately $1.6 million. This proposed sale follows a pattern of dispositions by Kapadia, who has sold over $2.8 million in shares in the past three months. The shares to be sold were acquired through the exercise of options. This ongoing selling activity by a former executive could be interpreted as a move for personal liquidity or a lack of confidence.
At the time of this filing, HRMY was trading at $35.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $25.52 to $40.87. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.